TY - JOUR
T1 - HNF1B and PAX2 mutations are a common cause of renal hypodysplasia in the CKiD cohort
AU - Thomas, Rosemary
AU - Sanna-Cherchi, Simone
AU - Warady, Bradley A.
AU - Furth, Susan L.
AU - Kaskel, Frederick J.
AU - Gharavi, Ali G.
N1 - Funding Information:
We thank the patients for their participation in this study. We thank Catarina Quinzii and Michio Hirano at The H. Houston Merritt Center for Neuromuscular and Mitochondrial Disorders at Columbia University for assistance with MLPA. This study was supported by 1R01DK080099 (AGG). Rosemary Thomas is supported by the T32 NIH training grant. Simone Sanna-Cherchi is supported by the American Heart Association Scientist Development Grant (0930151N) and the American Society of Nephrology Career Development Grant. Data in this manuscript were collected by the Chronic Kidney Disease in Children prospective cohort study (CKiD) with clinical coordinating centers (Principal Investigators) at the Children’s Mercy Hospital and the University of Missouri, Kansas City (Bradley Warady, MD) and the Children’s Hospital of Philadelphia (Susan Furth, MD, PhD), the central laboratory (Principal Investigator) at the Department of Pediatrics, University of Rochester Medical Center (George Schwartz, MD), and the data coordinating center (Principal Investigator) at the Johns Hopkins Bloomberg School of Public Health (Alvaro Muñoz, PhD). The CKiD is funded by the National Institute of Diabetes and Digestive and Kidney Diseases, with additional funding from the National Institute of Child Health and Human Development, and the National Heart, Lung, and Blood Institute (U01 DK066143, U01 DK066174, U01 DK082194, U01 DK066116). The CKiD website is located at https://doi.org/www.statepi.jhsph.edu .
PY - 2011/6
Y1 - 2011/6
N2 - Malformations of the kidney and lower urinary tract are the most frequent cause of end-stage renal disease in children. Mutations in HNF1B and PAX2 commonly cause syndromic urinary tract malformation. We searched for mutations in HNF1B and PAX2 in North Americanchildren with renal aplasia and hypodysplasia (RHD) enrolled in the Chronic Kidney Disease in Children Cohort Study (CKiD). We identified seven mutations in this multiethnic cohort (10% of patients). In HNF1B, we identified a nonsense (p.R181X), a missense (p.S148L),and a frameshift (Y352fsX352) mutation, and one whole gene deletion. In PAX2, we identified one splice site (IVS4-1G>T), one missense (p.G24E), and one frameshift (G24fsX28) mutation. All mutations occurred in Caucasians, accounting for 14% of disease in this subgroup. The absence of mutations in other ethnicities is likely due to the limited sample size. There were no differences in clinical parameters (age, baseline eGFR, blood pressure, body mass index, progression) between patients with or without HNF1B and PAX2 mutations. A significant proportion of North American Caucasian patients with RHD carry mutations in HNF1B or PAX2 genes. These patients should be evaluated for complications (e.g., diabetes for HNF1B mutations, colobomas for PAX2) and referred for genetic counseling.
AB - Malformations of the kidney and lower urinary tract are the most frequent cause of end-stage renal disease in children. Mutations in HNF1B and PAX2 commonly cause syndromic urinary tract malformation. We searched for mutations in HNF1B and PAX2 in North Americanchildren with renal aplasia and hypodysplasia (RHD) enrolled in the Chronic Kidney Disease in Children Cohort Study (CKiD). We identified seven mutations in this multiethnic cohort (10% of patients). In HNF1B, we identified a nonsense (p.R181X), a missense (p.S148L),and a frameshift (Y352fsX352) mutation, and one whole gene deletion. In PAX2, we identified one splice site (IVS4-1G>T), one missense (p.G24E), and one frameshift (G24fsX28) mutation. All mutations occurred in Caucasians, accounting for 14% of disease in this subgroup. The absence of mutations in other ethnicities is likely due to the limited sample size. There were no differences in clinical parameters (age, baseline eGFR, blood pressure, body mass index, progression) between patients with or without HNF1B and PAX2 mutations. A significant proportion of North American Caucasian patients with RHD carry mutations in HNF1B or PAX2 genes. These patients should be evaluated for complications (e.g., diabetes for HNF1B mutations, colobomas for PAX2) and referred for genetic counseling.
KW - Children
KW - Chronic kidney disease
KW - HNF1B
KW - PAX2
KW - Renal hypodysplasia
UR - http://www.scopus.com/inward/record.url?scp=79959953210&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=79959953210&partnerID=8YFLogxK
U2 - 10.1007/s00467-011-1826-9
DO - 10.1007/s00467-011-1826-9
M3 - Article
C2 - 21380624
AN - SCOPUS:79959953210
SN - 0931-041X
VL - 26
SP - 897
EP - 903
JO - Pediatric Nephrology
JF - Pediatric Nephrology
IS - 6
ER -